Jacques-Eric Gottenberg, PhD

CHU
Strasbourg, France

 Specialized post-graduate studies of Rheumatology-Paris-2003
 Diploma of supplementary specialized studies –Immunopathology-Ile de France-2005 to 2006
 Specialized in statistics applied to medicine-Clinical Research option-STARC-Paris-2003
 Graduate of university Musculoskeletal Ultrasound-Paris-2003

Disclosure information not submitted.

Presentation(s):

• 1429: Acute Cardiovascular Events Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a Nationwide Cohort Study: RELATION Study

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2050: Stratification on Baseline Interferon Scores and Use of CRESS to Improve the Design of Future Trials in Sjögren's Syndrome: Post Hoc Analysis from a Randomized Controlled Trial

  Monday, November 14, 2022
  1:40 PM – 1:45 PM Eastern Time

• 1984: Malignancies Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a National Study: RELATION Study

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• 2050: Stratification on Baseline Interferon Scores and Use of CRESS to Improve the Design of Future Trials in Sjögren's Syndrome: Post Hoc Analysis from a Randomized Controlled Trial

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time